Fall 2017 Newsletter

Follow our latest updates in our Newsletters and Annual Reports

Fall 2017 Newsletter
7th Residency Announcement

Exciting Residency Announcement!

ACGME approves seventh resident complement; first increase in over 30 years!

Grand Rounds

Grand Rounds and Case Studies

Check out our weekly presentations



USC Ophthalmology Researchers Find More
Effective Treatments For Blinding Eye Diseases


Case Study: It’s Morphin’ Time

Wong Bedrood
Presenter: Brandon Wong, MD Discussant: Sahar Bedrood, MD, PhD


  • 41-year-old female with history of decreased vision and pain in the right eye for one day

Exam Findings

  • S/C: 2+ injection OD, quiet OS
  • Cornea: 1+ edema OD, clear OS
  • AC: shallow with trace flare OD, deep/quiet OS
  • Iris: anterior bowing OD, flat OS
  • Lens: dense white cataract OD, 1+NSC OS
  • AV: no view OD, quiet OS
Figure 1
Figure 1: Representative photograph of eye with phacomorphic glaucoma obtained from AAO. Image courtesy of: emedicine.medscape.com/article/1204917-overview
  • Gonioscopy
    • OD closed in all four quadrants
    • OS open to SS/TM in all four quadrants
  • Fundus Exam
    • OD no view
    • OS CDR 0.3, macula flat, vessels WNL, mild NPDR
    • B scan OD
    • Retina and macula flat

Differential Diagnosis

  • Phacomorphic glaucoma
  • Acute angle closure glaucoma
  • Neovascular glaucoma
  • Phacolytic glaucoma
  • Lens particle glaucoma
  • Phacoantigenic glaucoma
  • Lens subluxation


  • Phacomorphic glaucoma


  • Acquired mass effect of mature cataract causes pathologic angle narrowing
    • Can occur rapidly with lens intumescence
    • Must be distinguished from primary angle closure glaucoma


  • Cosopt, Alphagan, IV Diamox administered with no improvement in IOP
  • Laser peripheral iridotomy performed with patency noted and gush of fluid; IOP decreased to 65
  • IV Mannitol given; IOP decreased to 52
  • Patient scheduled for cataract surgery with phacoemulsification (iris hooks + cortex aspiration with 25g needle)
  • POM#1 visual acuity was 20/50, IOP 14 without any anti-glaucoma medications

Prognosis and Future Directions

  • Typically good visual acuity but may be dependent on presenting IOP as well as duration of symptoms (depending on study final VA range from 20/20 to 20/50 in majority of patients)
  • RNFL thickness is reduced in superior and inferior quadrants after phacomorphic glaucoma
  • Combined cataract surgery with trabeculectomy may be indicated in patients with long-standing symptoms given concern for persistent angle closure due to synechiae, although combined surgery does not appear to have better IOP control or better visual outcomes compared with cataract surgery alone


  • Ramakrishnan R et al. Visual prognosis, intraocular pressure control and complications in phacomorphic glaucoma following manual small incision cataract surgery. Indian J Ophthal.2010 Jul-Aug;58(4):303-6.
  • Tham CCY et al. Immediate argon laser peripheral iridoplasty (ALPI) as initial treatment for acute phacomorphic angle-closure (phacomorphic glaucoma) before cataract extraction: a preliminary study. Eye (Lond). 2005 Jul. 19(7):778-783.
  • Lee JWY et al. Retrospective case series on the long-term visual and intraocular pressure outcomes of phacomorphic glaucoma. Eye. 2010. 24:1675-1680.
  • Lee JW et al. Retrospective analysis of the risk factors for developing phacomorphic glaucoma. Indian J Ophthal. 2011 Nov-Dec;59(6):471-4.
  • Angra SK, Pradhan R, Garg SP. Cataract induced glaucoma-an insight into management. Indian J Ophthal. 1991 Jul-Sep;39:97-101.
  • Jain IS, Gupta A, Dogra MR, Gangwar DN, Dhir SP. Phacomorphic glaucoma-management and visual prognosis. Indian J Ophthal.1983;31:648-53.
  • Lee JWY et al. Argon laser peripheral iridoplasty versus systemic intraocular pressure-lowering medications as immediate management for acute phacomorphic angle closure. Clin Ophthalmol. 2013 Jan;7:63-69.


Section Editors

  • Vivek Patel, MD, Associate Professor of Clinical Ophthalmology, Program Director, vivek.patel@med.usc.edu
  • Jesse Berry, MD, Assistant Professor of Clinical Ophthalmology, Associate Program Director, jesse.berry@med.usc.edu

    Produced by: Monica Chavez, John Daniel, Joseph Yim and Dr. Vivek Patel
Scroll Up To Top

USC Roski Eye Institute

1450 San Pablo St., 4th Floor,
Los Angeles, CA 90033

USC Roski Eye Institute

65 N. First Ave., Suite 101,
Arcadia, CA 91006

USC Roski Eye Institute

625 S. Fair Oaks Ave., Suite 400,
Pasadena, CA 91105

USC Roski Eye Institute
USC Village

835 W. Jefferson Blvd., Suite 1720
Los Angeles, CA 90089

Children’s Hospital
Los Angeles

4650 Sunset Blvd.,
Los Angeles, CA 90027

View Full Desktop Version

Coronavirus (COVID-19) Announcement

Due to ongoing developments with COVID-19, we are only able to see patients with urgent eye problems at this time. If you have any questions or concerns, please call us at 323-442-6335.